aim
studi
reveal
infect
dynam
bovin
respiratori
syncyti
viru
brsv
bovin
parainfluenza
viru
type
bovin
herpesviru
bovin
viral
diarrhea
viru
bvdv
bovin
adenoviru
type
bovin
coronaviru
bcov
import
viral
pathogen
respiratori
diseas
complex
rumin
analysi
regress
period
matern
deriv
antibodi
optimum
vaccin
time
calv
recommend
total
farm
group
larg
medium
small
size
enterpris
accord
anim
popul
newborn
calv
n
deliv
calendar
month
farm
studi
blood
sampl
collect
calv
month
age
blood
sampl
also
taken
dam
first
sampl
neutral
antibodi
titer
detect
use
serum
neutral
test
sn
new
bvdv
infect
earli
stage
life
determin
calv
matern
antibodi
began
decreas
month
brsv
month
bvdv
bcov
conclud
matern
antibodi
begin
decreas
month
possibl
first
exposur
calv
respiratori
virus
month
therefor
recommend
first
vaccin
program
includ
prime
booster
dose
appli
month
age
furthermor
revaccin
anim
month
booster
dose
also
suggest
bovin
respiratori
diseas
brd
common
health
problem
cattl
herd
gulliksen
et
al
brd
classifi
import
welfar
health
problem
calv
financi
loss
relat
brd
due
anim
mortal
bodi
weight
loss
yield
loss
veterinari
fee
medic
cost
although
respiratori
diseas
found
cattl
age
declin
passiv
immun
wean
time
entranc
feedlot
calv
suscept
due
intens
stress
exposur
pathogen
mugglicockett
et
al
dutch
dairi
farm
heifer
younger
month
old
infect
econom
loss
estim
per
heifer
due
pneumonia
studi
shown
calcul
loss
one
season
outbreak
per
heifer
month
old
van
der
felsklerx
et
al
furthermor
estim
annual
econom
loss
due
respiratori
tract
infect
million
usa
smith
contribut
brd
total
morbid
case
usa
estim
approxim
similarli
report
feedlot
death
edward
galyean
et
al
loneragan
et
al
spread
brd
infect
among
young
popul
extrem
rapid
calv
infect
brd
within
first
day
arriv
feedlot
buhman
et
al
insuffici
level
matern
deriv
antibodi
kimman
et
al
adrenocorticalimmunosuppress
factor
ie
stress
crowd
barn
bad
shelter
condit
lead
increas
incid
infect
calv
gulliksen
et
al
one
viral
agent
well
bacteria
report
etiolog
brd
et
al
import
viral
agent
brd
case
bovin
respiratori
syncyti
viru
brsv
bovin
herpesviru
type
bovin
parainfluenza
viru
type
bovin
viral
diarrhea
viru
bvdv
bovin
adenoviru
serotyp
et
al
et
al
autio
et
al
gulliksen
et
al
bovin
rhinoviru
bovin
coronaviru
bovin
reoviru
serotyp
occasion
isol
kurogi
et
al
richer
et
al
decaro
et
al
addit
mycoplasma
bovi
mannheimia
haemolytica
histophilu
somni
pasteurella
multocida
accompani
viral
agent
prognosi
clinic
ill
becom
dramat
wors
et
al
dabo
et
al
rice
et
al
commonli
accept
primari
pathogen
brd
viral
agent
immun
gap
ie
time
laps
regress
period
matern
antibodi
format
antibodi
vaccin
vaccin
clinic
protect
becom
even
import
brd
bvd
virus
persist
cattl
popul
persist
infect
individu
ipi
mcclurkin
et
al
may
creat
lifelong
latenc
primari
infect
ackermann
et
al
also
report
brsv
bcov
may
persist
within
herd
heckert
et
al
valarch
et
al
viru
clearanc
outbreak
aleniu
et
al
elvand
reintroduct
new
viral
strain
larsen
et
al
report
season
incid
brd
case
gener
higher
autumn
winter
stott
et
al
aim
studi
reveal
infect
dynam
import
viral
agent
involv
brd
determin
regress
period
matern
deriv
antibodi
optimum
age
first
vaccin
studi
carri
three
locat
karacabey
bursa
provinc
turkey
blood
sampl
collect
total
cattl
herd
depend
anim
densiti
total
number
anim
includ
calv
cow
heifer
herd
classifi
smallscal
enterpris
total
anim
number
mediumscal
enterpris
total
anim
number
largescal
enterpris
total
anim
number
tabl
farm
visit
monthli
accompani
farm
veterinarian
blood
sampl
collect
visit
record
clinic
case
herd
visit
suppli
veterinarian
clinic
case
also
sampl
laboratori
diagnosi
data
shown
anim
studi
dairi
cattl
farm
holsteinfresian
breed
either
semiintens
close
manag
tabl
calv
born
onemonth
period
juli
farm
select
studi
follow
month
blood
sampl
collect
serolog
test
calv
month
age
june
juli
none
calv
vaccin
examin
virus
studi
dam
n
also
sampl
first
sampl
period
june
demonstr
immunolog
statu
dam
largeand
mediumscal
enterpris
vaccin
inactiv
complet
virion
vaccin
examin
virus
tabl
vaccin
program
appli
dam
farm
includ
first
vaccin
month
age
booster
dose
month
age
follow
rappel
vaccin
one
year
apart
inactiv
bcov
vaccin
appli
dam
month
give
birth
blood
sampl
collect
vacutain
tube
venipunctur
serum
separ
centrifug
rpm
c
min
inactiv
water
bath
c
min
store
c
test
monthli
farm
visit
data
clinic
statu
studi
calv
well
calv
farm
also
obtain
farm
veterinarian
tabl
follow
circul
virus
herd
sampl
anim
test
immunolog
statu
bvdv
brsv
bcov
strain
cooper
strain
bav
serotyp
formerli
obtain
depart
virolog
ankara
univers
faculti
veterinari
medicin
turkey
bcov
strain
mebu
obtain
pendik
veterinari
control
research
institut
istanbul
turkey
bvdv
strain
nadl
atu
strain
brsv
obtain
institut
virolog
justusliebig
univers
faculti
veterinari
medicin
giessengermani
madinderbi
bovin
kidney
mdbk
cell
line
use
viru
propag
serum
neutral
test
dulbecco
mem
supplement
fetal
calf
serum
fc
use
cell
cultur
furthermor
cell
line
fc
test
absenc
pestiviru
contamin
throughout
studi
studi
serum
neutral
test
sn
perform
detect
viral
antibodi
describ
frey
liess
predilut
serum
sampl
also
accept
minimum
posit
titer
valu
brsv
bvdv
bcov
use
serum
sampl
parallel
column
row
micropl
use
first
row
ml
predilut
sampl
ad
twofold
dilut
prepar
brsv
bvdv
bcov
equal
volum
dilut
test
viru
ad
two
well
use
viru
control
ml
dilut
viru
two
blank
ml
dmem
two
hour
incub
period
neutral
co
c
appli
wherea
virus
incub
one
hour
ml
mdbk
cell
suspens
cellsml
ad
well
test
result
score
invert
light
microscop
day
incub
complet
inhibit
viru
propag
individu
well
accept
posit
result
highest
serum
dilut
posit
result
record
antibodi
titer
test
viru
sampl
antibodi
posit
last
dilut
retest
extens
final
dilut
rate
studi
geometr
mean
antibodi
titer
use
statist
comparison
fischer
exact
test
employ
statist
analysi
effect
enterpris
size
season
distribut
clinic
sign
p
spearman
correl
analysi
use
analyz
relationship
matern
deriv
antibodi
level
dam
antibodi
level
serolog
statu
antibodi
titer
test
anim
detect
serum
neutral
assay
popul
n
tabl
calv
found
seroposit
brsv
chang
level
antibodi
titer
sampl
period
number
seroposit
calv
increas
month
declin
occur
month
number
seroposit
calv
began
increas
month
number
calv
seroposit
declin
month
exhibit
increas
end
studi
bvdv
increas
seroposit
observ
month
follow
decreas
seroposit
calf
number
month
number
seroposit
calv
start
decreas
first
month
though
increas
detect
month
number
bcov
seroposit
calv
start
decreas
month
increas
month
except
brsv
chang
antibodi
titer
test
virus
compat
number
seroposit
calv
tabl
addit
chang
seroposit
rate
increas
detect
seroconvert
chang
seroneg
seroposit
state
calf
number
mostli
month
age
tabl
high
number
seroposit
anim
among
dam
determin
virus
except
dam
popul
seropreval
brsv
bvdv
bcov
respect
tabl
base
number
seroposit
calv
enterpris
size
correl
dam
antibodi
statu
matern
deriv
antibodi
season
distribut
clinic
sign
examin
signific
differ
detect
among
larg
mediumand
smallscal
enterpris
regard
brsv
bcov
infect
p
howev
signific
differ
determin
largeand
mediumscal
enterpris
also
signific
variat
bvdv
largeand
mediumscal
enterpris
well
largeand
smallscal
enterpris
p
posit
correl
transfer
matern
deriv
antibodi
dam
calf
determin
virus
except
bcov
brsv
r
p
r
p
r
p
bvdv
r
p
r
p
bcov
r
p
examin
season
distribut
clinic
sign
show
respiratori
viral
infect
common
autumn
follow
winter
summer
spring
p
tabl
econom
impact
brd
ignor
intens
cattl
enterpris
certain
viral
pathogen
main
caus
respiratori
diseas
complex
adult
cattl
calv
present
field
studi
analyz
infect
dynam
brsv
bvdv
bcov
intens
manag
largescal
n
well
medium
n
small
n
scale
cattl
herd
although
base
upon
acquir
data
declin
matern
deriv
antibodi
level
observ
possibl
vaccin
time
suggest
comprehens
studi
use
determin
period
vaccin
consid
number
seroconvert
calv
popul
n
infect
viral
agent
examin
studi
detect
sampl
period
tabl
present
paper
associ
one
viral
agent
bovin
respiratori
infect
shown
mani
studi
et
al
autio
et
al
gulliksen
et
al
consist
et
al
studi
popul
brsv
remain
almost
constant
level
number
anim
differ
immun
status
due
shortterm
matern
immun
may
enabl
continu
circul
viru
herd
baker
et
al
matern
antibodi
brsv
fail
prevent
scatter
replic
viru
van
der
poel
et
al
infect
occur
newborn
despit
high
matern
antibodi
titer
baker
et
al
subclin
infect
remain
herd
reinfect
occur
frequent
van
der
poel
et
al
addit
follow
acquir
immun
antibodi
brsv
detect
year
later
aleniu
et
al
elvand
thu
antibodi
detect
follow
period
studi
may
deriv
previou
infect
sampl
period
least
calv
popul
seroposit
brsv
tabl
opposit
elvand
due
seroposit
seroconvert
calf
number
gener
low
among
brsvinfect
calv
bvdvinfect
calv
sampl
period
tabl
number
seroposit
calv
age
month
analyz
shown
carri
brsv
bcov
infect
tabl
outcom
agreement
result
et
al
mani
studi
stott
et
al
kimman
et
al
van
der
poel
et
al
shown
calv
like
becom
reinfect
brsv
month
age
addit
increas
number
calv
seroposit
infect
month
sampl
period
indic
studi
viral
agent
simultan
circul
natur
condit
tabl
despit
agent
increas
detect
number
seroposit
calv
geometr
mean
antibodi
titer
bvdv
second
month
age
tabl
antibodi
respons
bvdv
reach
detect
level
week
infect
howard
et
al
addit
matern
antibodi
earlylif
infect
may
also
caus
increas
antibodi
thu
postul
situat
observ
indic
bvd
viru
may
circul
earli
period
life
birth
anoth
possibl
intrauterin
infect
prior
parturit
henc
calv
seroposit
month
due
primari
bvdv
infect
rather
matern
immun
increas
number
seroposit
calv
second
month
occur
unlik
bvdv
geometr
mean
antibodi
titer
valu
decreas
tabl
develop
low
titer
antibodi
respons
infect
calv
high
rate
matern
antibodi
catabol
thought
caus
reduct
geometr
mean
antibodi
titer
presenc
earlyperiod
infect
also
postul
high
brsv
mean
antibodi
titer
observ
sampl
period
tabl
antibodi
titer
bvdv
bcov
reach
lowest
level
month
reach
lowest
level
month
amount
matern
antibodi
vari
depend
dam
immun
statu
well
colostrum
quantiti
qualiti
total
degrad
matern
antibodi
brsv
bvdv
report
requir
month
baker
et
al
van
der
poel
et
al
fulton
et
al
number
seroposit
calv
geometr
mean
valu
antibodi
titer
quit
low
compar
studi
virus
includ
first
month
sampl
therefor
conclus
matern
antibodi
adequ
consid
sampl
calv
may
low
antibodi
titer
shown
limit
number
seroposit
calv
observ
data
number
seroposit
calv
start
declin
second
month
brsv
wherea
start
decreas
third
month
bvdv
bcov
antibodi
titer
lowest
level
month
brsv
month
bvdv
bcov
month
low
level
everi
sampl
period
observ
calv
new
infect
month
found
studi
virus
tabl
base
data
first
vaccin
time
month
age
minim
neg
impact
vaccin
passiv
immun
provid
stronger
immun
booster
dose
also
recommend
one
month
first
applic
recircul
studi
virus
parallel
increas
number
seroposit
calv
observ
month
tabl
indic
third
vaccin
use
period
contrast
previou
report
et
al
g
accord
chang
number
seroposit
calv
differ
found
among
larg
mediumand
smallscal
enterpris
preval
brsv
bcov
infect
thu
import
herd
size
may
matter
discuss
virus
earlier
studi
g
raaperi
et
al
studi
popul
sampl
relationship
herd
size
infect
seropreval
determin
present
studi
sampl
popul
follow
year
time
consequ
differ
studi
earlier
one
may
origin
differ
survey
method
point
number
seroneg
individu
herd
preval
infect
relat
preval
infect
herd
size
factor
rout
transmiss
propag
veloc
farmanim
densiti
region
direct
contact
rate
anim
number
visitor
biosafeti
rule
also
taken
consider
given
criteria
capac
herd
increas
direct
contact
anim
number
visitor
increas
automat
therefor
herd
size
classifi
one
main
risk
factor
respiratori
infect
reason
transit
matern
antibodi
examin
correl
antibodi
titer
dam
n
offspr
month
n
brsv
bvdv
signific
posit
correl
found
expect
despit
high
valu
bcov
mean
antibodi
titer
correl
detect
data
shown
one
possibl
caus
situat
implement
vaccin
bcov
end
pregnanc
increas
antibodi
titer
colostrum
case
antibodi
titer
dam
rapidli
declin
birth
matern
antibodi
catabol
occur
normal
pace
calv
overal
increas
number
seroposit
calv
virus
month
sampl
period
similar
previou
report
stott
et
al
van
der
poel
et
al
period
correspond
winter
season
howev
studi
anim
show
clinic
symptom
distribut
follow
spring
summer
autumn
winter
tabl
thu
obtain
data
confirm
season
chang
one
import
risk
factor
respiratori
viral
infect
p
matern
antibodi
receiv
colostrum
start
declin
month
calv
mostli
encount
viral
infect
first
time
month
age
though
bvdv
infect
may
occur
earli
stage
life
first
month
accord
result
studi
first
vaccin
calv
respiratori
virus
month
recommend
due
natur
inactiv
vaccin
booster
dose
also
advis
anoth
import
result
studi
possibl
introduct
infect
month
age
therefor
revaccin
anim
month
booster
dose
may
use
extend
level
durat
matern
immun
vaccin
dam
may
benefici
prior
birth
calf
elimin
anim
latent
infect
persist
infect
bvdv
support
health
statu
herd
